We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

September 30, 2009

Genzyme Corporation v. Endo Pharmaceuticals Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. October 6, 2009

    Genzyme Sues Endo In Latest Renagel ANDA Suit

    Genzyme Corp. has accused Endo Pharmaceuticals Inc. of infringing a patent for Renagel by seeking regulatory permission to sell a generic version of the kidney disease treatment in the U.S. before the patent expires.


To view the parties, register now.